- Home
- AXSM vs QTWO Comparison
AXSM vs QTWO Comparison
Compare AXSM & QTWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AXSM
- QTWO
- Stock Information
- Founded
- AXSM 2012
- QTWO 2004
- Country
- AXSM United States
- QTWO United States
- Employees
- AXSM N/A
- QTWO N/A
- Industry
- AXSM Biotechnology: Pharmaceutical Preparations
- QTWO Computer Software: Prepackaged Software
- Sector
- AXSM Health Care
- QTWO Technology
- Exchange
- AXSM Nasdaq
- QTWO Nasdaq
- Market Cap
- AXSM 4.4B
- QTWO 4.8B
- IPO Year
- AXSM 2015
- QTWO 2014
- Fundamental
- Price
- AXSM $98.19
- QTWO $104.97
- Analyst Decision
- AXSM Strong Buy
- QTWO Buy
- Analyst Count
- AXSM 14
- QTWO 16
- Target Price
- AXSM $124.93
- QTWO $89.50
- AVG Volume (30 Days)
- AXSM 536.9K
- QTWO 728.1K
- Earning Date
- AXSM 11-12-2024
- QTWO 11-06-2024
- Dividend Yield
- AXSM N/A
- QTWO N/A
- EPS Growth
- AXSM N/A
- QTWO N/A
- EPS
- AXSM N/A
- QTWO N/A
- Revenue
- AXSM $338,457,000.00
- QTWO $675,537,000.00
- Revenue This Year
- AXSM $40.67
- QTWO $13.21
- Revenue Next Year
- AXSM $69.27
- QTWO $11.34
- P/E Ratio
- AXSM N/A
- QTWO N/A
- Revenue Growth
- AXSM 51.47
- QTWO 10.92
- 52 Week Low
- AXSM $60.28
- QTWO $34.59
- 52 Week High
- AXSM $105.00
- QTWO $105.64
- Technical
- Relative Strength Index (RSI)
- AXSM 61.45
- QTWO 74.02
- Support Level
- AXSM $90.86
- QTWO $95.31
- Resistance Level
- AXSM $105.00
- QTWO $104.50
- Average True Range (ATR)
- AXSM 4.06
- QTWO 3.92
- MACD
- AXSM 0.44
- QTWO 0.37
- Stochastic Oscillator
- AXSM 64.04
- QTWO 96.95
About AXSM Axsome Therapeutics Inc.
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and AXS-14. It manages its business as one operating segment and reporting unit, which is the business of developing and delivering novel therapies for the management of CNS disorders.
About QTWO Q2 Holdings Inc.
Q2 Holdings Inc. is a provider of cloud-based virtual banking solutions for regional financial institutions to deliver mobile banking services to retail and commercial end-users who wish to bank anywhere and anytime. Its solutions operate on an integrated tablet-first platform which provides financial institutions a comprehensive view of account holder activity and meets the regulatory and security requirements applicable to the industry. The firm generates revenue from subscription-based arrangements for software offerings. A large majority of the firm's revenue is generated in the United States.